Comments
Biocon Ltd has announced that its Executive Chairperson Kiran Mazumdar-Shaw has been appointed to the Board of Trustees of Memorial Sloan Kettering Cancer Center (MSK), a leader in cancer treatment and research, based in New York, US.
The company in a regulatory filing to exchanges, said Kiran Mazumdar-Shaw is among the 52 members on the board and will serve for a term of three years with effect from April 14, 2021 and she is the first woman of Indian nationality to be appointed for this prestigious role.
Memorial Sloan Kettering is ranked as one of the top two hospitals for cancer care in the US for more than 30 years and among the nation’s top pediatric hospitals for cancer care, according to US News & World Report.
Memorial Sloan Kettering maintains one of the world’s most dynamic programs of cancer research, with more than 120 research laboratories that are focused on better understanding every type of the disease.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.